BLUE EARTH DIAGNOSTICS TEAM

Marco Campione brings more than 25 years of industry experience to his role as Chief Executive Officer (CEO). Prior to joining Blue Earth Diagnostics from GE HealthCare, he most recently served as Executive Director and Global Head of Contrast Media, General Manager Pharmaceutical Diagnostics North America and President GE HealthCare Inc. He was responsible for the Pharmaceutical Diagnostics business unit in North America, with oversight for its strategy, management, and overall commercial operations throughout the United States and Canada. Before joining GE HealthCare, Marco worked at FiatAvio as integrated logistic support leader for military engines and was an Anti-aircraft Artillery Technical Control Officer in the Italian Army. He is a graduate of the Polytechnic of Turin (BE, ME), and received his MBA from University of Turin, and La Sorbonne, Paris.

Dr. Teoh, Blue Earth Diagnostics’ Chief Medical Officer (CMO), reports to CEO Marco Campione. Eugene joined the Company in 2018 as European (EU) Medical Director and was subsequently promoted to Vice President (VP) Clinical Development. Prior to joining Blue Earth Diagnostics, Eugene served as a consultant and investigator to the Company in research to advance its prostate cancer pipeline. Eugene obtained his medical degree from Imperial College School of Medicine, in London, UK, and completed his initial medical training in Oxford and London. This was followed by specialist training in radiology at Oxford, leading to board-certification in radiology with sub-specialization in diagnostic nuclear medicine. Eugene is a member of the Royal College of Physicians and a Fellow of the Royal College of Radiologists in the UK, and holds a doctorate in cancer imaging from the University of Oxford. He has published his research in prestigious medical journals and presented at a variety of national and international meetings.

Jonathan Fitzpatrick is the Vice President Human Resources at Blue Earth Diagnostics. He joined Blue Earth Diagnostics in 2020. Jonathan has more than 24 years of experience in Human Resources, the majority of which has been spent with the Bracco Group which he joined in 2002. In those 24 years of careers he held various HR roles, leading HR for the Canadian operations of Bracco. He holds a Bachelor of Science in Industrial Relations from the University of Montreal and is a Chartered Human Resources Professional.

Caroline Foxton brings more than 20 years’ experience in oncology drug discovery and drug development to her role as Vice President, Innovation and Strategy at Blue Earth Diagnostics. She joined the company in 2021. Prior to Blue Earth, Caroline worked for Cancer Research UK within the Commercial Partnerships team and the Centre for Drug Development, providing strategic leadership to support the evaluation and development of novel technologies, often in partnership with industry. For nearly a decade, she worked for Cancer Research Technology Ltd as a Cell Biology Group Leader, delivering drug discovery programmes.  Caroline’s academic training includes a BSc (Hons) in Biochemistry and a PhD in Cell Biology, both from the University of Southampton UK, after which she undertook 5 years of post-doctoral research in the field of translational oncology, funded by Imperial Cancer Research Fund in association with Centocor Inc. 

Matthew Miller brings more than 20 years’ experience in nuclear medicine and clinical trial research to his role as Head of Research & Development at Blue Earth Diagnostics. Matthew joined the company at its outset in 2014, initially as Head of Imaging and subsequently as Vice President of R&D Operations. Prior to Blue Earth, Matthew was a Project Leader within the Imaging R&D division at GE Healthcare, overseeing PET oncology clinical trials in Europe, USA, and Asia. He has previously held positions as a Principal Medical Physicist within Imaging R&D, GE Healthcare, and as a Nuclear Medicine Physicist at the Royal London Hospital, London. Matthew has a BSc in Theoretical Physics from the University of Nottingham, a MSc in Medical Physics from the University of Surrey and a PhD in Medical Physics from the Medical Research Council Cyclotron Unit, Hammersmith Hospital, London, in association with the University of Surrey.

Matt Morrison is the Head of Operations and Supply Chain at Blue Earth Diagnostics Ltd. He joined Blue Earth Diagnostics in 2021.  Matt has more than 25 years of experience in the nuclear medicine industry. Prior to joining Blue Earth Diagnostics, he held leadership positions of increasing responsibility in R&D and Commercial product management at GE Healthcare. Matt holds a B.Sc. in Toxicology and Pharmacology and a Ph.D. from University College London.

Jaimala K. Pai is the General Counsel of Blue Earth Diagnostics. With a career spent predominantly in highly regulated life sciences and healthcare industries, Jaimala is a commercially focused legal executive with over twenty years’ experience. Prior to joining Bracco, Jaimala held various roles at Medtronic, most recently as Chief Counsel to the Cardiovascular Diagnostics & Services business. She has also held senior legal roles at Coloplast Corp. and UnitedHealthcare. She started her in-house career at Northwest Airlines, Inc. and worked for a large U.S. law firm after clerking on the Minnesota Court of Appeals. Jaimala was Chair of the Leadership Council on Legal Diversity Alumni Executive Council, was named a 2022 Notable General Counsel by Twin Cities Business, and was awarded Minnesota Lawyer's In-house Counsel Honoree for 2021. She holds a B.A. in Political Science from the University of Denver and a J.D. from the University of Minnesota Law School.  

Richard Petherick is the Vice President of Quality Assurance at Blue Earth Diagnostics. He has over 25 years of experience in life sciences, the majority of which has been spent in quality-related roles. Richard has a track record of developing Quality Management Systems and improving Quality and Compliance, having held industry and consulting roles of increasing seniority.  Before joining Blue Earth Richard was the Head of Quality at Britannia Pharmaceuticals. He has also held positions at GSK where he was a Director, R&D Quality and Wyeth where he worked in Global Quality and Compliance.  Richard holds an undergraduate degree from the University of Southampton.

Andrea Scampoli is the Chief Financial Officer at Blue Earth Diagnostics. Andrea has many years’ experience in Pharmaceuticals and Diagnostics and joined the Bracco Group in 2013. He has held several senior finance roles in different businesses and companies, DHL Express, PepsiCo and GE Industrial. He has a degree in Business Administration.

Terri Wilson is the President of Blue Earth Diagnostics Inc., and a member of its Board of Directors. She joined Blue Earth Diagnostics in 2016. Terri is passionate about how policy can impact access to both diagnostic imaging and therapy for patients fighting cancer.  Terri has more than 20 years of experience in the nuclear medicine industry. Prior to joining Blue Earth Diagnostics, she held leadership positions of increasing responsibility in sales, marketing, and market access at organizations such as PETNET Solutions, Siemens, Cardinal Health, and MITA (Medical Imaging & Technology Alliance). She began her career as a nuclear medicine technologist. Terri holds a B.S. in Nuclear Medicine from the University of Missouri and an MBA with a focus on Pharmaceutical Marketing from Saint Joseph’s University in Philadelphia, PA.